PPCB
Propanc Biopharma Inc

1,302
Mkt Cap
$3.06M
Volume
3,046.00
52W High
$11.00
52W Low
$0.1555
PE Ratio
-0.01
PPCB Fundamentals
Price
$0.193
Prev Close
$0.1952
Open
$0.1913
50D MA
$0.3745
Beta
0.00
Avg. Volume
646,918.75
EPS (Annual)
-$14.85
P/B
0.25
Rev/Employee
$0.00
$18.38
Loading...
Loading...
News
all
press releases
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·2mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·2mo ago
News Placeholder
When Wall Street Rotates, Biotech Innovators Emerge: The Untapped Opportunities in Oncology
Market rotations are as old as Wall Street itself. When capital exits overheated sectors like big tech, it often finds its way into undervalued industries ripe for rediscovery. The latest shift, away from pricey artificial intelligence and semiconductor stocks, has once again turned investors’ attention toward biotechnology. And within biotech, the most compelling breakthroughs are not in computing or automation, but in humanity’s longest-standing battle: defeating cancer.As institutional money seeks new opportunities, healthcare and biotech have emerged as natural ...
AllPennyStocks·2mo ago
News Placeholder
Why Propanc stock Is Tumbling In Premarket Today
The biotech firm announced a $4 million share sale alongside its Nasdaq uplisting, sending trading volumes surging to record levels.
Stocktwits·7mo ago
<
...
1
>

Latest PPCB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.